Why treat bedwetting?
Bedwetting is one of the most common childhood problems which can have a significant negative impact on a child’s emotional and social development.
Bedwetting does not always resolve by itself. If a child is 6 years old, still wets the bed and is unhappy and uncomfortable about bedwetting, treatment should be considered.
The recommended initial treatment for bedwetting is with a bedwetting alarm. Bedwetting alarms are effective in stopping bedwetting.
A bedwetting alarm is used to train the child to wake up and go to the toilet. The alarm will sound when the child begins to wet the bed.
For a child who continues to wet the bed despite alarm treatment, further advice should be sought from your doctor.
Why choose the WetAlert Enuresis Alarm?
WetAlert is a high quality product designed and tested in Australia.
WetAlert is affordable and costs less than about 3 months worth of pull-up nappies (if worn every day).
WetAlert is easy to use.
WetAlert comes with 12 months warranty.
WetAlert is ready for use with handy instructions and progress diary included.
Ferring Pharmaceuticals Pty Ltd | Bedwetting and Treatment
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis.
The company’s research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body’s own terms to enable doctors to combat numerous diseases and medical conditions.
The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world.
Ferring has its own production facilities in several European countries, in South America, Israel and China. With the acquisition of Bio-Technology General in 2005, it has capabilities in recombinant biotechnology as well as more traditional pharmaceutical manufacturing.
Ferring’s marketing, medical services and sales teams, led by corporate headquarters in Saint-Prex, Switzerland, operate from more than 45 countries and employ over 3200 people throughout the world, while treatments are available in more than 70 countries. This expansion has allowed Ferring to maintain a double digit annual growth rate over the last two decades.